How We Achieved a 95% Customer Retention Rate as a CRO? Expert Insights and Best Practices In the dynamic world of clinical research, solid vendor-sponsor partnerships and ensuring a high retention rate come with years of expertise, dedication, exceptional service provision, and good relationships. At NoyMed CRO, after a decade of experience in the industry, working on…
How to Ensure Patient Safety in Clinical Trials (2023)? The clinical trials landscape in 2023 is marked by significant potential for medical advancements, but it continues to confront a persistent challenge: ensuring patient safety. Safety concerns are a primary contributing factor to the failure of clinical trials. According to Hwang et al., an analysis of…
How to Design and Conduct Clinical Trials That Are Diverse and Inclusive? What are Diverse and Inclusive Clinical Trials? Diverse and inclusive clinical trials are clinical trials that include participants from all backgrounds, regardless of race, ethnicity, gender, sexual orientation, socioeconomic status, disability status, or other characteristics. This is important because it ensures that the…
Pharmacovigilance in Clinical Trials The Global Market | Trends | Contribution of CROs What is Pharmacovigilance in Clinical Trials? Pharmacovigilance (PV) in clinical trials is the science and practice of detecting, assessing, understanding, and preventing adverse effects (AEs), side effects, or other medicine-related problems. The sponsor and investigators are responsible for ensuring the safety of participants in clinical…
Adaptive Designs in Clinical Trials: Methodology, Benefits, Challenges, and Implementation In the rapidly evolving landscapes of clinical research and drug development, implementing adaptive design in clinical trials has emerged as a significant approach, increasing the efficacy of clinical trials. With over a decade of experience, NoyMed has been at the forefront of using adaptive clinical trial designs to achieve…
Streamlining Ophthalmology Clinical Trials: CROs Assisting Biotechnology, Pharmaceutical, and Medical Device Companies What are Ophthalmology Clinical Trials?Ophthalmology clinical trials are research studies that test new medicines, therapies, medical devices, or procedures for eye diseases. These studies determine the safety and effectiveness of new treatments and compare them to existing therapies.Ophthalmology clinical trials may focus on…
Elevating Oncology Clinical Trials: Biotech, Pharma, and Medical Device Firms Outsourcing to CROs What are Oncology Clinical Trials? Oncology clinical trials are research studies that test new cancer treatments in people. These trials can help doctors find new ways to improve cancer patients’ treatment and quality of life. Several oncology clinical trials are based on…
Advancing Cardiovascular Clinical Trials: CROs Assisting Biotechnology, Pharmaceutical, and Medical Device Companies What are Cardiovascular Clinical Trials? A cardiovascular clinical trial is a research study designed to evaluate the safety and effectiveness of new medications, medical devices, procedures, or interventions related to cardiovascular health. Cardiovascular or cardiology clinical trials are essential for understanding how different…
The Partnership of 2 CROs: Providing Collaborative Services and Solutions The Contribution of Contract Research Organizations to Drug Development Contract research organizations (CROs) play a vital role in the global drug development process. CROs provide clinical operations, biostatistics, SAS programming, full data management, and other solutions to pharmaceutical companies, biotechnology firms, medical device companies, other CROs, and academic institutions….
Partnering With a CRO: How Can CROs Provide Solutions to Biotechnology Companies? The Contribution of Biotechnology to Drug DevelopmentBiotechnology has emerged as a driving force behind revolutionary advancements in drug development. Over the years, it has transformed how drugs are manufactured, designed, and identified, increasing the efficacy of global drug development. From personalized medicine to…
